iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

PixoTech® licensing shifted in as iXensor’s new growth engine to meet self-testing strong demand in the post-pandemic era Taipei, Taiwan / Osaka, Japan, April 27th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announced that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical corporation headquartered in Japan, has…

read more

iXensor Eveline·Care Telehealth Fertility Service Covered in MobiHealth News

iXensor latest Eveline·Care service enables fertility consultants to access a patient’s fertility data and remotely monitor their conditions in real-time. MobiHealth News and other media have covered this telehealth fertility tool as below: “The Eveline·Care telehealth service enables fertility consultants to access patient’s ovulation test data and recorded symptoms via a…

read more

iXensor’s Eveline·Care telehealth empowering fertility services to assist patients’ conceptions with at-home test monitoring

Palo Alto, California / Taipei, Taiwan, September 14th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, launches its new Eveline·Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly…

read more

iXensor levels up PixoTest® COVID-19 Ag Test with the launch of PixoHealth data management platform as the security solution for the new normalcy

PixoHealth Pass Admin App and Web Portal empowers safer reopening in the post-pandemic era

The GDPR-compliant PixoHealth Pass Admin Solution works with PixoTest® POCT COVID-19 Antigen Test to help organizations maintain COVID-19 free environments The PixoTest® POCT COVID-19 Antigen Test detects the key SARS-CoV-2 variants, including Alpha, Beta, Gamma and Delta Connected point-of-care screening is the critical security mechanism of the post-pandemic normalcy  …

read more